These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19709843)

  • 1. First report of Paenibacillus cineris from a patient with cystic fibrosis.
    Leão RS; Pereira RH; Ferreira AG; Lima AN; Albano RM; Marques EA
    Diagn Microbiol Infect Dis; 2010 Jan; 66(1):101-3. PubMed ID: 19709843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis.
    Spilker T; Liwienski AA; LiPuma JJ
    Clin Microbiol Infect; 2008 May; 14(5):504-6. PubMed ID: 18325036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity.
    Rogers GB; Stressmann FA; Walker AW; Carroll MP; Bruce KD
    Expert Rev Mol Diagn; 2010 Mar; 10(2):187-96. PubMed ID: 20214537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic therapy for pulmonary exacerbations in adults with cystic fibrosis.
    Elpern EH; Patel G; Balk RA
    Medsurg Nurs; 2007 Oct; 16(5):293-8; quiz 299. PubMed ID: 18072667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis and the pseudomonads.
    Wright KC
    Br J Biomed Sci; 1996 Jun; 53(2):140-5. PubMed ID: 8757691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness analysis in cystic fibrosis.
    Doran C; Vos T
    J Cyst Fibros; 2005 Dec; 4(4):211-2. PubMed ID: 16230054
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis.
    Ramsey DM; Wozniak DJ
    Mol Microbiol; 2005 Apr; 56(2):309-22. PubMed ID: 15813726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical therapy of infections in neutropenic patients.
    Gaya H
    Br J Haematol; 1998 May; 101 Suppl 1():5-9. PubMed ID: 9607734
    [No Abstract]   [Full Text] [Related]  

  • 9. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaerobic bacteria in cystic fibrosis: pathogens or harmless commensals?
    Jones AM
    Thorax; 2011 Jul; 66(7):558-9. PubMed ID: 21415245
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bacterial infections of the lungs in mucoviscidosis patients].
    Hogardt M; Heesemann J
    MMW Fortschr Med; 2005 Jan; 147(4):38-40. PubMed ID: 15745340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
    Chest; 1988 Aug; 94(2 Suppl):97S-169S. PubMed ID: 3396440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bronchopulmonary infections in mucoviscidosis].
    Hein J; Wiersbitzky S; Wunderlich P
    Z Erkr Atmungsorgane; 1988; 170(2):201-11. PubMed ID: 3135674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of nebulized antibiotics in cystic fibrosis: evolution of protocol.
    Mukhopadhyay S; Singh M; Ogston S; Ryan G; Smyth R
    J R Soc Med; 1998; 91 Suppl 34(Suppl 34):25-9. PubMed ID: 9709385
    [No Abstract]   [Full Text] [Related]  

  • 15. Paenibacillus alvei Sepsis in a Neonate.
    DeLeon SD; Welliver RC
    Pediatr Infect Dis J; 2016 Mar; 35(3):358. PubMed ID: 26866854
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudomonas aeruginosa and the airways disease of cystic fibrosis.
    Hata JS; Fick RB
    Clin Chest Med; 1988 Dec; 9(4):679-89. PubMed ID: 3148384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients.
    Jørgensen IM; Johansen HK; Frederiksen B; Pressler T; Hansen A; Vandamme P; Høiby N; Koch C
    Pediatr Pulmonol; 2003 Nov; 36(5):439-46. PubMed ID: 14520728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolides in cystic fibrosis.
    McArdle JR; Talwalkar JS
    Clin Chest Med; 2007 Jun; 28(2):347-60. PubMed ID: 17467553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of immunoglobulin G against Mycobacterial antigen A60 in patients with cystic fibrosis and lung infection due to Mycobacterium abscessus.
    Ferroni A; Sermet-Gaudelus I; Le Bourgeois M; Pierre-Audigier C; Offredo C; Rottman M; Guillemot D; Bernède C; Vincent V; Berche P; Gaillard JL
    Clin Infect Dis; 2005 Jan; 40(1):58-66. PubMed ID: 15614693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis.
    Hawley HB; Lewis RM; Swartz DR; Gump DW
    Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.